Lv5
1600 积分 2022-09-20 加入
Optimizing management of stage IV EGFR mutant non‐small cell lung cancer in Asia: An expert opinion
1天前
待确认
Global patterns and trends in breast cancer incidence and mortality across 185 countries
9天前
已完结
BRAF fusion as resistance mechanism to osimertinib in EGFR-mutated NSCLC: a case report and review of literature
9天前
已关闭
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial
14天前
已完结
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER+/HER2- breast cancer
14天前
已完结
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
14天前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
14天前
已完结
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers
14天前
已完结
Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer
14天前
已完结
First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer
14天前
已完结
皖公网安备34019202002308
